Assignee
OPUS GENETICS INC
US·7 granted patents·4 pending applications·7 citations·filing 2019–2025
Top patents by PatentIndex Score
11 records- 0195US12350366B2Aqueous ophthalmic solutions of phentolamine and medical uses thereofOPUS GENETICS INC·Filed 2023·Granted Jul 8, 2025·2 cites·23 claims
- 0292US12201616B2Methods and compositions for treatment of mydriasisOPUS GENETICS INC·Filed 2022·Granted Jan 21, 2025·2 cites·24 claims
- 0392US12201615B2Methods and compositions for treatment of mydriasisOPUS GENETICS INC·Filed 2022·Granted Jan 21, 2025·2 cites·32 claims
- 0483US2025262149A1Aqueous ophthalmic solutions of phentolamine and medical uses thereofOPUS GENETICS INC·Filed 2025·Application pending·0 cites
- 0583US2025248930A1Aqueous ophthalmic solutions of phentolamine and medical uses thereofOPUS GENETICS INC·Filed 2025·Application pending·0 cites
- 0683US2025248931A1Aqueous ophthalmic solutions of phentolamine and medical uses thereofOPUS GENETICS INC·Filed 2025·Application pending·0 cites
- 0777US12161629B2Methods and compositions for treatment of glaucoma and related conditionsOPUS GENETICS INC·Filed 2019·Granted Dec 10, 2024·1 cites·20 claims
- 0874US12576066B2Methods and compositions for treatment of mydriasisOPUS GENETICS INC·Filed 2025·Granted Mar 17, 2026·0 cites·54 claims
- 0974US12576067B2Methods and compositions for treatment of mydriasisOPUS GENETICS INC·Filed 2025·Granted Mar 17, 2026·0 cites·54 claims
- 1073US12312308B2Salts and esters of APX3330 and therapeutic uses thereofOPUS GENETICS INC·Filed 2024·Granted May 27, 2025·0 cites·27 claims
- 1155US2025162995A1Phentolamine mesylate and therapeutic uses thereofOPUS GENETICS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OPUS GENETICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →